Christine Scheve

Christine’s biotechnology experience spans tissue engineering, drug delivery, molecular biophysics and nanotechnology. She served as an advisor to science and technology startups at Powershift Group, a venture development firm, and worked at a top-level clinical, regulatory and quality consulting firm specializing in medical and in-vitro diagnostic devices. Christine began her career as a research scientist at the University of Texas at Austin where she specialized in molecular biophysics and nanotechnology. She has also conducted research at The Methodist Hospital Research Institute and was a recipient of the Waterloo Institute of Nanotechnology Fellowship at The University of Waterloo in Canada. She has authored several peer-reviewed publications and holds a bachelor’s and a master’s degree in biomedical engineering from the University of Texas at Austin.